Roles of NMDARs in maintenance of the mouse cerebrovascular endothelial cell-constructed tight junction barrier

Toxicology

Volumn 339, Issue , 2016, Pages 40-50

  Chen, Jui Tai ^a,b   Chen, Tyng Guey ^b   Chang, Yung Chia ^b   Chen, Cheng Yu ^a   Chen, Ruei Ming ^a,b,c  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

BBB; Cerebrovascular endothelial cells; MAPKs; MMPs; NMDA receptor; Occludin tight junction

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; DIZOCILPINE; GELATINASE A; GELATINASE B; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; OCCLUDIN; RECEPTOR SUBUNIT; AMINO ACID RECEPTOR BLOCKING AGENT; BLOOD CLOTTING FACTOR 8; DIZOCILPINE MALEATE; GPRIN1 PROTEIN, MOUSE; NERVE PROTEIN; NR2B NMDA RECEPTOR;

ANIMAL CELL; ARTICLE; BLOOD BRAIN BARRIER; BRAIN BLOOD VESSEL; CALCIUM TRANSPORT; CONFOCAL MICROSCOPY; CONTROLLED STUDY; ELECTRIC RESISTANCE; ENDOTHELIUM CELL; IMMUNOBLOTTING; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; TIGHT JUNCTION; ANIMAL; BIOSYNTHESIS; BRAIN CHEMISTRY; BRAIN CIRCULATION; CYTOLOGY; DRUG EFFECTS; GENETICS; INSTITUTE FOR CANCER RESEARCH MOUSE; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIUM;

ANIMALS; BLOOD-BRAIN BARRIER; BRAIN CHEMISTRY; CEREBROVASCULAR CIRCULATION; DIZOCILPINE MALEATE; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; EXCITATORY AMINO ACID ANTAGONISTS; FACTOR VIII; MALE; MAP KINASE SIGNALING SYSTEM; MICE; MICE, INBRED ICR; NERVE TISSUE PROTEINS; OCCLUDIN; RECEPTORS, N-METHYL-D-ASPARTATE; TIGHT JUNCTIONS;

EID: 84949446876     PISSN: 0300483X     EISSN: 18793185     Source Type: Journal    
DOI: 10.1016/j.tox.2015.11.006     Document Type: Article

References (53)

1. Abbott N.J., Patabendige A.A., Dolman D.E., Yusof S.R., Begley D.J. Structure and function of the blood-brain barrier. Neurobiol. Dis. 2010, 37:13-25.
2. Anderson M., Suh J.M., Kim E.Y., Dryer S.E. Functional NMDA receptors with atypical properties are expressed in podocytes. Am. J. Physiol. Cell Physiol. 2011, 300:C22-C32.
3. András I.E., Deli M.A., Veszelka S., Hayashi K., Hennig B., Toborek M. The NMDA and AMPA/KA receptors are involved in glutamate-induced alterations of occludin expression and phosphorylation in brain endothelial cells. J. Cereb. Blood Flow Metab. 2007, 27:1431-1443.
4. Ballabh P., Braun A., Nedergaard M. The blood-brain barrier: an overview: structure, regulation, and clinical implications. Neurobiol. Dis. 2004, 16:1-13.
5. Beart P.M., Sheehan K.A., Manallack D.T. Absence of N-methyl-d-aspartate receptors on ovine cerebral microvessels. J. Cereb. Blood Flow Metab. 1988, 8:879-882.
6. Cederberg-Helms H.C., Uhd-Nielsen C., Brodin B. Glutamate efflux at the blood-brain barrier: cellular mechanisms and potential clinical relevance. Arch. Med. Res. 2014, 45:639-645.
7. Chang H.C., Lin K.H., Tai Y.T., Chen J.T., Chen R.M. Lipoteichoic acid-induced TNF-α and IL-6 gene expressions and oxidative stress production in macrophages are suppressed by ketamine through downregulating Toll-like receptor 2-mediated activation of ERK1/2 and NFκB. Shock 2010, 33:485-492.
8. Chang H.C., Chen T.G., Tai Y.T., Chen T.L., Chiu W.T., Chen R.M. Resveratrol attenuates oxidized LDL-evoked Lox-1 signaling and consequently protects against apoptotic insults to cerebrovascular endothelial cells. J. Cereb. Blood Flow Metab. 2011, 31:842-854.
9. Chang H.C., Tai Y.T., Cherng Y.G., Lin J.W., Liu S.H., Chen T.L., Chen R.M. Resveratrol attenuates high-fat diet-induced disruption of the blood-brain barrier and protects brain neurons from apoptotic insults. J. Agric. Food Chem. 2014, 62:3466-3475.
10. Chang C.Y., Lui T.N., Lin J.W., Lin Y.L., Hsing C.H., Wang J.J., Chen R.M. Roles of microRNA-1 in hypoxia-induced apoptotic insults to neural cells. Arch. Toxicol. 2015, 10.1007/s00204-014-1364-x.
11. Chao T.S., Byron K.L., Lee K.M., Villereal M., Rosner M.R. Activation of MAP kinases by calcium-dependent and calcium-independent pathways. Stimulation by thapsigargin and epidermal growth factor. J. Biol. Chem. 1992, 267:19876-19883.
12. Chen Y., Lu Q., Schneeberger E.E., Goodenough D.A. Restoration of tight junction structure and barrier function by downregulation of the mitogen-activated protein kinase pathway in ras-transformed Madin-Darby canine kidney cells. Mol. Biol. Cell 2000, 11:849-862.
13. Chen R.M., Chen T.L., Lin Y.L., Chen T.G., Tai Y.T. Ketamine reduces nitric oxide biosynthesis in human umbilical vein endothelial cells by down-regulating endothelial nitric oxide synthase expression and intracellular calcium levels. Crit. Care Med. 2005, 33:1044-1049.
14. Chen T.G., Chen T.L., Chang H.C., Tai Y.T., Cherng Y.G., Chang Y.T., Chen R.M. Oxidized low-density lipoprotein induces apoptotic insults to mouse cerebral endothelial cells via a Bax-mitochondria-caspase protease pathway. Toxicol. Appl. Pharmacol. 2007, 219:42-53.
15. Choi D.W., Rothman S.M. The role of glutamate neurotoxicity in hypoxic-ischemic neuronal death. Annu. Rev. Neurosci. 1990, 13:171-182.
16. Chio C.C., Lin J.W., Cheng H.A., Chiu W.T., Wang Y.H., Wang J.J., Hsing C.H., Chen R.M. MicroRNA-210 targets antiapoptotic Bcl-2 expression and mediates hypoxia-induced apoptosis of neuroblastoma cells. Arch. Toxicol. 2013, 87:458-468.
17. Costello D.A., Lyons A., Denieffe S., Browne T.C., Cox F.F., Lynch M.A. Long term potentiation is impaired in membrane glycoprotein CD200-deficient mice: a role for toll-like receptor activation. J. Biol. Chem. 2011, 286:34722-34732.
18. Crone C., Olesen S.P. Electrical resistance of brain microvascular endothelium. Brain Res. 1982, 241:49-55.
19. Domoki F., Kis B., Gáspár T., Bari F., Busija D.W. Cerebromicrovascular endothelial cells are resistant to l-glutamate. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2008, 295:R1099-R1108.
20. Engelhardt B. Development of the blood-brain barrier. Cell Tissue Res. 2003, 314:119-129.
21. Fuller G., Veitch K., Ho L.K., Cruise L., Morris B.J. Activation of p44/p42 MAP kinase in striatal neurons via kainate receptors and P13 kinase. Mol. Brain Res. 2001, 89:126-132.
22. Hardingham G.E. Coupling of the NMDA receptor to neuroprotective and neurodestructive events. Biochem. Soc. Trans. 2009, 37:1147-1160.
23. Hawkins R.A. The blood-brain barrier and glutamate. Am. J. Clin. Nutr. 2009, 90:867S-874S.
24. Ishrat T., Sayeed I., Atif F., Hua F., Stein D.G. Progesterone and allopregnanolone attenuate blood-brain barrier dysfunction following permanent focal ischemia by regulating the expression of matrix metalloproteinases. Exp. Neurol. 2010, 226:183-190.
25. Kempski O. Cerebral edema. Semin. Nephrol. 2001, 21:303-307.
26. 2[U+207A]-calcineurin signaling. J. Neurosci. 2012, 32:8845-8854.
27. Leung J.C., Travis B.R., Verlander J.W., Sandhu S.K., Yang S.G., Zea A.H., Weiner I.D., Silverstein D.M. Expression and developmental regulation of the NMDA receptor subunits in the kidney and cardiovascular system. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2002, 283:964-971.
28. Lin Y.L., Chang H.C., Chen T.L., Chang J.H., Chiu W.T., Lin J.W., Chen R.M. Resveratrol protects against oxidized LDL-induced breakage of the blood-brain barrier by lessening disruption of tight junctions and apoptotic insults to mouse cerebrovascular endothelial cells. J. Nutr. 2010, 140:2187-2192.
29. Liu K., Li Z., Wu T., Ding S. Role of rho kinase in microvascular damage following cerebral ischemia reperfusion in rats. Int. J. Mol. Sci. 2011, 12:1222-1231.
30. Liu W.Y., Wang Z.B., Zhang L.C., Wei X., Li L. Tight junction in blood-brain barrier: an overview of structure, regulation, and regulator substances. CNS Neurosci. Ther. 2012, 18:609-615.
31. Love S. Oxidative stress in brain ischemia. Brain Pathol. 1999, 9:119-131.
32. Manabe S.I., Gu Z., Lipton S.A. Activation of matrix metalloproteinase-9 via neuronal nitric oxide synthase contributes to NMDA-induced retinal ganglion cell death. Investig. Ophthalmol. Vis. Sci. 2005, 46:4747-4753.
33. Mashkina A.P., Cizkova D., Vanicky I., Boldyrev A.A. NMDA receptors are expressed in lymphocytes activated both in vitro and in vivo. Cell. Mol. Neurobiol. 2010, 38:901-907.
34. Morley P., Small D.L., Murray C.L., Mealing G.A., Poulter M.O., Durkin J.P., Stanimirovic D.B. Evidence that functional glutamate receptors are not expressed on rat or human cerebromicrovascular endothelial cells. J. Cereb. Blood Flow Metab. 1998, 18:396-406.
35. Mou L., Kang Y., Zhou Y., Zeng Q., Song H., Wang R. Neurokinin-1 receptor directly mediates glioma cell migration by up-regulation of matrix metalloproteinase-2 (MMP-2) and membrane type 1-matrix metalloproteinase (MT1-MMP). J. Biol. Chem. 2013, 288:306-318.
36. Neuhaus W., Freidl M., Szkokan P., Berger M., Wirth M., Winkler J., Gabor F., Pifl C., Noe C.R. Effects of NMDA receptor modulators on a blood-brain barrier in vitro model. Brain Res. 2011, 1394:49-61.
37. Preston E., Webster J. A two-hour window for hypothermic modulation of early events that impact delayed opening of the rat blood-brain barrier after ischemia. Acta Neuropathol. 2004, 108:406-412.
38. Rao R. Occludin phosphorylation in regulation of epithelial tight junctions. Ann. N.Y. Acad. Sci. 2009, 1165:62-68.
39. Reijerkerk A., Kooij G., van der Pol S.M., Leyen T., Lakeman K., van Het Hof B., Vivien D., de Vries H.E. The NR1 subunit of NMDA receptor regulates monocyte transmigration through the brain endothelial cell barrier. J. Neurochem. 2010, 113:447-453.
40. Sanz-Clemente A., Nicoll R.A., Roche K.W. Diversity in NMDA receptor composition: many regulators, many consequences. Neuroscientist 2013, 19:62-75.
41. Sharp C.D., Hines I., Houghton J., Warren A., Jackson T.H., Jawahar A., Nanda A., Elrod J.W., Long A., Chi A., Minagar A., Alexander J.S. Glutamate causes a loss in human cerebral endothelial barrier integrity through activation of NMDA receptor. Am. J. Physiol. Heart Circ. Physiol. 2003, 285:H2592-H2598.
42. Simeone T.A., Sanchez R.M., Rho J.M. Molecular biology and ontogeny of glutamate receptors in the mammalian central nervous system. J. Child Neurol. 2004, 19:343-360.
43. Singh V., Edwards N.J. Advances in the critical care management of ischemic stroke. Stroke Res. Treat. 2013, 2013:510481.
44. Wang Y., Zhang J., Yi X.J., Yu F.S. Activation of ERK1/2 MAP kinase pathway induces tight junction disruption in human corneal epithelial cells. Exp. Eye Res. 2004, 78:125-136.
45. Wilhelm I., Fazakas C., Krizbai I.A. In vitro models of the blood-brain barrier. Acta Neurobiol. Exp. 2011, 71:113-128.
46. Wu T.T., Chen T.L., Chen R.M. Lipopolysaccharide triggers macrophage activation of inflammatory cytokine expression, chemotaxis, phagocytosis, and oxidative ability via a toll-like receptor 4-dependent pathway: validated by RNA interference. Toxicol. Lett. 2009, 191:195-202.
47. Wu T.T., Chen T.L., Loon W.S., Tai Y.T., Cherng Y.G., Chen R.M. Lipopolysaccharide stimulates syntheses of toll-like receptor 2 and surfactant protein-A in human alveolar epithelial A549 cells through upregulating phosphorylation of MEK1 and ERK1/2 and sequential activation of NF-κB. Cytokine 2011, 55:40-47.
48. Yang G., Chan P.H., Chen S.F., Babuna O.A., Simon R.P., Weinstein P.R. Reduction of vasogenic edema and infarction by MK-801 in rats after temporary focal cerebral ischemia. Neurosurgery 1994, 34:339-345.
49. Yang Y., Estrada E.Y., Thompson J.F., Liu W., Rosenberg G.A. Matrix metalloproteinase-mediated disruption of tight junction proteins in cerebral vessels is reversed by synthetic matrix metalloproteinase inhibitor in focal ischemia in rat. J. Cereb. Blood Flow Metab. 2007, 27:697-709.
50. Zanassi P., Paolillo M., Feliciello A., Avvedimento E.V., Gallo V., Schinelli S. cAMP-dependent protein kinase induces cAMP-response element-binding protein phosphorylation via an intracellular calcium release/ERK-dependent pathway in striatal neurons. J. Biol. Chem. 2001, 276:11487-11495.
51. 2+/CaM-dependent ERK activation in cerebral ischemia. J. Neurosci. Res. 2008, 86:2733-2745.
52. Zhuravliova E., Barbakadze T., Natsvlishvili N., Mikeladze D.G. Haloperidol induces neurotoxicity by the NMDA receptor downstream signaling pathway, alternative from glutamate excitotoxicity. Neurochem. Int. 2007, 50:976-982.
53. Zipp F., Aktas O. The brain as a target of inflammation: common pathways link inflammatory and neurodegenerative diseases. Trends Neurosci. 2006, 29:518-527.